Viking Therapeutics (NASDAQ:VKTX – Get Free Report) is expected to release its earnings data after the market closes on ...

The Minnesota Vikings have lots of work to do this offseason. With a plethora of impending free agents, general manager Kwesi ...

JP Morgan analyst Matthew Boss reiterated an Overweight rating for Viking Holdings, raising the price target to $58 from $50.

The Minnesota Vikings are primed to franchise tag QB Sam Darnold and then trade him in an unprecedented NFL move.

The Minnesota Vikings have a lot of crucial decisions to make when it comes to the future of the franchise. Free agency is coming up in less than six weeks and the Vikings can change their trajectory ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $32.87 which represents a slight increase of $0.22 or 0.67% from the prior close of $32.65. The stock opened at $32.87 and ...

In this article, we are going to take a look at where Viking Therapeutics ... For this week’s list, we only focused on ...

Viking Therapeutics struggles with FDA approval and scaling up. Find out why VKTX stock’s path remains uncertain, despite its ...

Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $34.94 which represents a slight increase of $0.89 or 2.61% from the prior close of $34.05. The stock opened at $33.85 and ...

The Vikings have 20 meaningful contributors from 2024 who are set to become free agents. Here's our plan for staying ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Viking’s focus on educational experiences ... market share within the expanding global vacation market. Price Action: VIK shares are trading higher by 5.79% at $47.75 on the last check Friday.